表紙:インスリンペンの世界市場:2021年~2025年
市場調査レポート
商品コード
1014750

インスリンペンの世界市場:2021年~2025年

Global Insulin Pens Market 2021-2025

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.12円
インスリンペンの世界市場:2021年~2025年
出版日: 2021年05月25日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のインスリンペンの市場規模は、2021年から2025年の間に34億4000万米ドル成長し、予測期間中は8%のCAGRで成長する見込みです。

同市場は、糖尿病の有病率の増加、先進国における政府の糖尿病予防の取り組みによって推進されています。

当レポートではインスリンペンの世界市場の全体的な分析、市場規模と予測、動向、成長要因、課題、および約25のベンダーをカバーする分析を提供しています。

目次

  • エグゼクティブサマリー
    • 市場概要
  • 市場情勢
    • 市場のエコシステム
    • バリューチェーン分析
  • 市場規模
    • 市場の定義
    • 市場セグメント分析
    • 2020年の市場規模
    • 市場の見通し:2020年から2025年の予測
    • COVID-19が医療業界に与える影響
  • ファイブフォース分析
    • ファイブフォースまとめ
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争の脅威
    • 市況
  • 市場セグメンテーション:製品別
    • 市場セグメント
    • 製品別の比較
    • 再利用可能なインスリンペン:市場規模と予測(2020年~2025年)
    • 使い捨てインスリンペン:市場規模と予測(2020年~2025年)
    • 製品別の市場機会
  • 顧客情勢
  • 地域別情勢
    • 地域別セグメンテーション
    • 地域別比較
    • 北米:市場規模と予測(2020年~2025年)
    • 欧州:市場規模と予測(2020年~2025年)
    • アジア:市場規模と予測(2020年~2025年)
    • その他の地域:市場規模と予測(2020年~2025年)
    • 主要国
    • 地域別の市場機会
    • 市場の推進力
    • 市場の課題
    • 市場動向
  • ベンダー情勢
    • 概要
    • ベンダー情勢
    • 創造的破壊の状況
  • ベンダー分析
    • 対象ベンダー
    • ベンダーの市場ポジショニング
    • Biocon Ltd.
    • Eli Lilly and Co.
    • Emperra GmbH E-Health Technologies
    • Innovation Zed Ltd.
    • Medtronic Plc
    • Nemera
    • Novo Nordisk AS
    • Owen Mumford Ltd.
    • Sanofi SA
  • 付録
    • 調査範囲
    • 米ドルの通貨換算レート
    • 調査手法
    • 略語一覧
目次
Product Code: IRTNTR70608

Technavio has been monitoring the insulin pens market and it is poised to grow by $ 3.43 billion during 2021-2025, progressing at a CAGR of about 8% during the forecast period. Our report on the insulin pens market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of diabetes cases and rising government initiatives to prevent diabetes in developed countries. In addition, the growing prevalence of diabetes cases is anticipated to boost the growth of the market as well.

The insulin pens market analysis includes the product segment and geographic landscape.

Technavio's insulin pens market is segmented as below:

By Product

  • Reusable insulin pens
  • Disposable insulin pens

By Geography

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing product launchesas one of the prime reasons driving the insulin pens market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on insulin pens market covers the following areas:

  • Insulin pens market sizing
  • Insulin pens market forecast
  • Insulin pens market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insulin pens market vendors that include Becton, Dickinson and Co., Biocon Ltd., Eli Lilly and Co., Emperra GmbH E-Health Technologies, Innovation Zed Ltd., Medtronic Plc, Nemera, Novo Nordisk AS, Owen Mumford Ltd., and Sanofi SA. Also, the insulin pens market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
    • Impact of COVID-19 on healthcare industry
  • Five Forces Analysis
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Product
    • Market segments
    • Comparison by Product
    • Reusable insulin pens - Market size and forecast 2020-2025
    • Disposable insulin pens - Market size and forecast 2020-2025
    • Market opportunity by Product
  • Customer Landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Biocon Ltd.
    • Eli Lilly and Co.
    • Emperra GmbH E-Health Technologies
    • Innovation Zed Ltd.
    • Medtronic Plc
    • Nemera
    • Novo Nordisk AS
    • Owen Mumford Ltd.
    • Sanofi SA
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Reusable insulin pens - Market size and forecast 2020-2025 ($ million)
  • 24: Reusable insulin pens - Year-over-year growth 2020-2025 (%)
  • 25: Disposable insulin pens - Market size and forecast 2020-2025 ($ million)
  • 26: Disposable insulin pens - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Becton, Dickinson and Co. - Overview
  • 48: Becton, Dickinson and Co. - Business segments
  • 49: Becton, Dickinson and Co. - Key offerings
  • 50: Becton, Dickinson and Co. - Key customers
  • 51: Becton, Dickinson and Co. - Segment focus
  • 52: Biocon Ltd. - Overview
  • 53: Biocon Ltd. - Business segments
  • 54: Biocon Ltd. - Key offerings
  • 55: Biocon Ltd. - Key customers
  • 56: Biocon Ltd. - Segment focus
  • 57: Eli Lilly and Co. - Overview
  • 58: Eli Lilly and Co. - Business segments
  • 59: Eli Lilly and Co. - Key offerings
  • 60: Eli Lilly and Co. - Key customers
  • 61: Eli Lilly and Co. - Segment focus
  • 62: Emperra GmbH E-Health Technologies - Overview
  • 63: Emperra GmbH E-Health Technologies - Product and service
  • 64: Emperra GmbH E-Health Technologies - Key offerings
  • 65: Emperra GmbH E-Health Technologies - Key customers
  • 66: Emperra GmbH E-Health Technologies - Segment focus
  • 67: Innovation Zed Ltd. - Overview
  • 68: Innovation Zed Ltd. - Product and service
  • 69: Innovation Zed Ltd. - Key offerings
  • 70: Innovation Zed Ltd. - Key customers
  • 71: Innovation Zed Ltd. - Segment focus
  • 72: Medtronic Plc - Overview
  • 73: Medtronic Plc - Business segments
  • 74: Medtronic Plc - Key offerings
  • 75: Medtronic Plc - Key customers
  • 76: Medtronic Plc - Segment focus
  • 77: Nemera - Overview
  • 78: Nemera - Product and service
  • 79: Nemera - Key offerings
  • 80: Nemera - Key customers
  • 81: Nemera - Segment focus
  • 82: Novo Nordisk AS - Overview
  • 83: Novo Nordisk AS - Business segments
  • 84: Novo Nordisk AS - Key offerings
  • 85: Novo Nordisk AS - Key customers
  • 86: Novo Nordisk AS - Segment focus
  • 87: Owen Mumford Ltd. - Overview
  • 88: Owen Mumford Ltd. - Product and service
  • 89: Owen Mumford Ltd. - Key offerings
  • 90: Owen Mumford Ltd. - Key customers
  • 91: Owen Mumford Ltd. - Segment focus
  • 92: Sanofi SA - Overview
  • 93: Sanofi SA - Business segments
  • 94: Sanofi SA - Key offerings
  • 95: Sanofi SA - Key customers
  • 96: Sanofi SA - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations